BioCentury
ARTICLE | Financial News

Invirsa raises $520K in seed round

November 10, 2017 8:46 PM UTC

Infectious disease play Invirsa Inc. (Columbus, Ohio) raised $520,000 in a seed financing led by CincyTech. Initial investor Rev1 Ventures also participated.

Invirsa's lead candidate, INV-102, is in preclinical testing to treat acute conjunctivitis and upper respiratory tract infections. The therapy is a derivative of an undisclosed naturally occurring small molecule...